PharmaZen - Latest News [Page 1]

PharmaZen pre-tax profit jumps 134% for half year

Thursday, 1 August 2019, 2:13 pm | PharmaZen

It has taken biotechnology company PharmaZen Limited just six months to surpass its record full year result of 2018. More >>

PharmaZen delivers record profit on 72% jump in sales

Thursday, 4 April 2019, 10:21 am | PharmaZen

On the back of a 72% increase in sales, Biotechnology company PharmaZen Limited has topped the $1 million post-tax profit for the first time after a profit turnaround of $1.5 million compared with last year. More >>

Record half-year result for PharmaZen

Thursday, 13 September 2018, 10:54 am | PharmaZen

Biotechnology company PharmaZen Limited has recorded a record half year pre-tax profit for the six months ending June 2018. More >>

PharmaZen continues strong capex investment

Monday, 5 September 2016, 10:58 am | PharmaZen

In the six months to June, 2016, PharmaZen had a half-year profit of $290,000 (after interest and depreciation) on turnover of $3.71m compared with a $230,000 profit for the same period last year (turnover $3.63m). Shares in PharmaZen are traded through ... More >>

PharmaZen reports significant profit jump

Friday, 8 April 2016, 11:16 am | PharmaZen

An increase in capacity and production efficiencies from recently completed capital projects, have seen biotechnology company PharmaZen post a record surplus. More >>

PharmaZen notches strong increase in tough export market

Thursday, 3 April 2014, 4:00 pm | PharmaZen

Biotechnology company PharmaZen Ltd has reported a 38% increase in its annual surplus before tax of $739,114 for the year ended December 31, 2013, despite a challenging environment for exporters. More >>

Challenging period for PharmaZen; future bright

Monday, 16 September 2013, 1:56 pm | PharmaZen

In a six-month period that wasn’t without challenges, biotechnology company PharmaZen posted a $223,000 profit after interest and depreciation. Turnover was $3.198 million compared with $3.470 million last year. More >>

PharmaZen Builds For The Future On Back Of Record Surplus

Thursday, 28 March 2013, 9:31 am | PharmaZen

Media Release March 28, 2013 PharmaZen Builds For The Future On Back Of Record Surplus More >>

Trial results boost buoyant PharmaZen

Friday, 27 April 2012, 11:00 am | PharmaZen

Media Release April 27, 2012 Trial results boost buoyant PharmaZen Eager anticipation surrounding trial results for its bone health product range has biotechnology company PharmaZen confidently looking forward to the next 12 months on the back of another ... More >>

Solid half for PharmaZen but head winds looming

Thursday, 25 August 2011, 1:26 pm | PharmaZen

Inspite of a solid half year, biotechnology company PharmaZen believes the strengthening New Zealand dollar and the present global uncertainty will make for more difficult trading conditions throughout the rest of the year. More >>

Earthquakes and dollar fail to rattle PharmaZen

Thursday, 21 April 2011, 10:53 am | PharmaZen

Despite the on-going drag of a stubbornly high New Zealand dollar and the September earthquake, biotechnology company PharmaZen is pleased to report both an increase in volume and profit as well as a lift in confidence for the future. More >>

Encouraging half for PharmaZen despite high dollar

Thursday, 29 July 2010, 1:06 pm | PharmaZen

Despite a stubbornly high New Zealand dollar, biotechnology company PharmaZen has announced a solid first half with a profit of $210,000 after interest and depreciation on a turnover of $2.980 million, with further improvement likely over the rest of ... More >>

PharmaZen ‘cautiously optimistic’ after year

Friday, 9 April 2010, 2:46 pm | PharmaZen

Despite difficult trading conditions, uncertainty over the global recovery and a stubbornly high dollar, Biotechnology company PharmaZen is cautiously optimistic it has weathered the worst of the storm and is looking for an improved 2010. More >>

Strong result and positive outlook for PharmaZen

Monday, 6 April 2009, 2:35 pm | PharmaZen

Biotechnology company PharmaZen is looking forward to a strong 2009, following its excellent turnaround in 2008, spearheaded by new products and new markets. More >>

Bright half for PharmaZen

Wednesday, 12 November 2008, 9:55 am | PharmaZen

Biotechnology company PharmaZen has announced a sharply improved first half with a profit of $202,000 after interest and depreciation on a turnover of $3.087 million, with further improvement likely over the rest of the year. More >>

PharmaZen rationalisation - company back in black

Monday, 19 March 2007, 10:55 am | PharmaZen

Biotechnology company PharmaZen has signalled it is back on track, posting an operating profit of $799,613 on improved turnover of $6.29 million for the year ended October 31, 2006. More >>

PharmaZen doubles capacity to keep up with demand

Thursday, 2 November 2006, 11:51 am | PharmaZen

Biotechnology company PharmaZen has just invested $1m in plant and machinery which will double the company's potential turnover from $7 million to $14 million per year. With demand outstripping supply for the company's animal and human health products, ... More >>

PharmaZen appoints new director

Monday, 25 September 2006, 4:43 pm | PharmaZen

Ken Fergus has been appointed to the board of biotechnology company PharmaZen. Currently a director of a number of substantial private companies in the manufacturing, property and service sectors, he was a partner in Ernst & Young and its antecedent firms from ... More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL